The potential of novel ribonucleotide reductase inhibitors, Didox and Trimidox, compared to hydroxyurea to enhance abacavir antiviral activity in vivo.

被引：0
|
作者：
Elford, H
Sumpter, R
Inayat, M
Gallicchio, V
机构：
[1] Univ Kentucky, Lexington, KY 40506 USA
[2] Mol Hlth Inc, Richmond, VA USA
来源：
ANTIVIRAL RESEARCH | 2002年 / 53卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
37
引用
收藏
页码：A46 / A46
页数：1
相关论文
共 15 条
  • [1] The potential of novel ribonucleotide reductase inhibitors, Didox and Trimidox, compared to hydroxyurea to enhance NRTI antiviral activity in vivo
    Sumpter, R
    Elford, H
    Inayat, M
    Sugg, T
    Tsai, P
    Gallicchio, V
    ANTIVIRAL RESEARCH, 2003, 57 (03) : A48 - A48
  • [2] Hydroxyurea (HU) and the novel ribonucleotide reductase inhibitors (RRI) trimidox (TX) and didox (DX) enhance the anti-viral activity of abacavir (ABC) in-vivo
    Sumpter, R
    Inayat, M
    Mayhew, C
    Yost, E
    Cibull, M
    Elford, H
    Gallicchio, V
    XIV INTERNATIONAL AIDS CONFERENCE: BASIC SCIENCES, 2002, : 211 - 214
  • [3] Ribonucleotide reductase inhibitors didox and trimidox compared to hydroxyurea to inhibit retrovirus replication alone or in combination with abacavir, ddl or tenofovir
    Sumpter, R
    Mayhew, C
    Inayat, M
    Sugg, T
    Tsai, P
    Elford, H
    Gallicchio, V
    ANTIVIRAL RESEARCH, 2004, 62 (02) : A29 - A29
  • [4] The potential of novel ribonucleotide reductase inhibitors, Didox and Trimidox, to reduce doxorubicin cardiotoxicity and enhance antitumor activity.
    Elford, HL
    Cardounel, AJ
    Mikhail, E
    Szekeres, T
    Zweier, JL
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3749S - 3749S
  • [5] In vivo examination of hydroxyurea and the novel ribonucleotide reductase inhibitors trimidox and didox in combination with the reverse transcriptase inhibitor abacavir: suppression of retrovirus-induced immunodeficiency disease
    Sumpter, LR
    Inayat, MS
    Yost, EE
    Duvall, W
    Hagan, E
    Mayhew, CN
    Elford, HL
    Gallicchio, VS
    ANTIVIRAL RESEARCH, 2004, 62 (03) : 111 - 120
  • [6] The in vitro inhibition of cytomegalovirus by novel ribonucleotide reductase inhibitors didox and trimidox
    Inayat, MS
    Gallicchio, VS
    Garvy, BA
    Elford, HL
    Oakley, OR
    ANTIVIRAL RESEARCH, 2005, 65 (03) : A74 - A75
  • [7] In vivo and in vitro comparison of the short-term hematopoietic toxicity between hydroxyurea and trimidox or didox, novel ribonucleotide reductase inhibitors with potential anti-HIV-1 activity
    Mayhew, CN
    Phillips, JD
    Greenberg, RN
    Birch, NJ
    Elford, HL
    Gallicchio, VS
    STEM CELLS, 1999, 17 (06) : 345 - 356
  • [8] Ribonucleotide reductase inhibitors hydroxyurea, didox, and trimidox inhibit human cytomegalovirus replication in vitro and synergize with ganciclovir
    Bhave, Sukhada
    Elford, Howard
    McVoy, Michael A.
    ANTIVIRAL RESEARCH, 2013, 100 (01) : 151 - 158
  • [9] Ribonucleotide reductase inhibitors and free radical scavengers Didox and Trimidox protect against Doxorubicin mediated cardiotoxicity and enhance antitumor activity.
    Sumpter, R
    Elford, HL
    Cardounel, AJ
    Tiravanti, E
    Loayza, G
    Zweier, JL
    Cancel, W
    Logan, P
    Gallicchio, VS
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6107S - 6107S
  • [10] Suppression of retrovirus-induced immunodeficiency disease (murine AIDS) by trimidox and didox - Novel ribonucleotide reductase inhibitors with less bone marrow toxicity than hydroxyurea
    Mayhew, CN
    Mampuru, LJ
    Chendil, D
    Ahmed, MM
    Phillips, JD
    Greenberg, RN
    Elford, HL
    Gallicchio, VS
    ANTIVIRAL RESEARCH, 2002, 56 (02) : 167 - 181
12